THE FDA DESIGNATED BREAKTHROUGH DEVICE

Detect and monitor brain diseases through typing cadence

How do we perform our magic?

Simple: Measure typing inconsistency

Detect and monitor neurological diseases and psychiatric disorders through typing cadence.

NeuraMetrix Typing Cadence (TC) is a patented digital biomarker (US Patents 10,694,947 and 10,694,987) measuring typing inconsistency.

Why do we do what we do?

Measurement is a huge barrier to better care for brain diseases and psychiatric disorders.

Or as Dr. Adam Gazzaley puts it

Imprecise, inaccessible, and outdated assessments of cognition dominate the mental health world - Dr. Adam Gazzaley, UCSF

We want to enable dramatically better care for Neurological and Psychiatry patients through a much more precise and accurate measure of brain health over time.​​​

From the experts

//

We have been looking for this for 30 years


- Dr. Robert W. Mahley, MD, PhD – Gladstone Institutes
​​​​​​​
//

We train our Huntington’s patients intensively. I am amazed that the effects are so clearly shown in the inconsistency scores.


- Dr. Christina Lang, MD – Universität Ulm, Germany
​​​​​​​
//

This will revolutionize how we treat these poor patients


- CTO of major hospital system in Scandinavia
​​​​​​​
//

NeuraMetrix technology has potential to provide first-in-class early detection of affective disorders potentially fast-tracking diagnosis and reducing burden of illness


- Dr. Martin Schalling, MD, Professor of Medical Genetics Karolinska Institutet,  Chair Swedish Mental Health Fund
​​​​​​​

Some of our Partners

Sign up for our newsletter

Get the latest news from and about NeuraMetrix